Stem cell-based products for veterinary use: specific questions on tumorigenicity to be addressed by Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT)

Current version

PDF icon Problem statement

Deadline for comments: 30/09/2016

Reference numberEMA/CVMP/ADVENT/207268/2016
Published25/07/2016
Keywordsmesenchymal stem cells (MSCs), veterinary, tumorigenicity, homogeneity, biodistribution, amplification
DescriptionThis problem statement provides the basis for development of a guidance on tumorigenicity in relation to stem cell products intended for veterinary use. If you have any comments on the content of the document, use this. The completed comments form should be sent to vet-guidelines@ema.europa.eu.


Related content

Topics

How useful was this page?

Add your rating